Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technegas vs Xenon-133 for Pulmonary Embolism Diagnosis
NCT01458639Phase 3Terminated
- Sponsor
- Cyclomedica
- Start
- Aug 2012
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
A Phase 3 trial of Technegas in pulmonary embolism (PE), sponsored by Cyclomedica. Started Aug 2012; status: terminated.
02
Drugs
Technegas
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT01458639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458639.